Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. ONCODESIGN
  6. Actualités
  7. Autres langues
    ALONC   FR0011766229

ONCODESIGN

(ALONC)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur ONCODESIGN
04/11Oncodesign Strengthens the Intellectual Property of ODS 101 in Treating Inflammatory Bo..
26/10ONCODESIGN : Appoints Chief Development Officer
25/10Oncodesign Appoints Karine Lignel as Group Chief Development Officer
21/10ONCODESIGN : Starts R&D Deal with TiumBio for Fibrosis Drug Candidates
21/10Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
16/09Oncodesign Announces Unaudited Consolidated Sales Results for the Half Year Ended June ..
22/07GLOBAL MARKETS LIVE : AT&T, American Airlines, Biogen, Netflix, ABB...
21/07Oncodesign Announces Unaudited Consolidated Turnover Results for the First Half of 2021
05/07Oncodesign Appoints Aline Aubertin as New Independent Director
29/06EN DIRECTO DESDE LOS MERCADOS : Airbus, Alcon, FactSet, Wells Fargo, Ford, UBS, Zalando...
28/06Oncodesign Announces a Strategic Collaboration Agreement with Covalab
24/06GLOBAL MARKETS LIVE : Siemens, BHP Group, Visa, JP Morgan Chase, Proximus...
24/06EN DIRECTO DE LOS MERCADOS : Visa, Nestlé, BHP, Boeing, Tecan, Nike, Oncodesign ...
24/06ONCODESIGN : provides an update on its progress on RIPK2
24/06Oncodesign Provides Update on Its Progress on RIPK2
15/06Sube más, sube máaaas
14/06Servier and Oncodesign Announce the Selection of a Preclinical Candidate as Part of its..
19/05GLOBAL MARKETS LIVE : Target, Take-Two, Google, KKR, JP Morgan....
18/05InterSystems and Oncodesign Partner for the Optimization of Data Use to Enhance and Acc..
09/04Aguas tranquilas y un ligero viento de cola
09/04EN DIRECTO DESDE LOS MERCADOS : Michelin, Suez, Airbus, Dassault, Bénéteau, Cellectis, Cré..
08/04Oncodesign Reports Consolidated Earnings Results for the Year Ended December 31, 2020
15/02Oncodesign Société Anonyme commences an Equity Buyback Plan for 10% of its issued share..
28/01ONCODESIGN : Maintains Its Revenue and Operating Income at €38 Million in 2020 and is Anti..
28/01Oncodesign Société Anonyme Reports Unaudited Consolidated Revenue Results for the Year ..
2020ONCODESIGN : Announces a Share Ownership Plan for All Employees on the Occasion of the Gro..
2020ONCODESIGN : Announces Drug Discovery Cooperation With ViraTherapeutics, a Boehringer Inge..
2020ONCODESIGN Announces Drug Discovery Cooperation with ViraTherapeutics
2020ONCODESIGN : Obtains €15.9 Million of Non-dilutive Financing in the Form of a State-Guaran..
2020ONCODESIGN Obtains €15.9 Million of Non-Dilutive Financing in the Form of State-Guarant..
2020ONCODESIGN : First-half 2020 Results
2020Oncodesign Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 20..
2020ONCODESIGN : Announces a Capital Increase Reserved for the Company's Management Committee
2020ONCODESIGN : Reports Its First-half Revenue and a Strong Increase in Its Cash Position at ..
2020Oncodesign Reports Unaudited Consolidated Revenue Results for the First Half Ended June..
2020ONCODESIGN : and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Serv..
2020Oncodesign and Hitgen Announce A Strategic Partnership in Integrated Drug Discovery Ser..
2020Oncodesign Announces the Creation of its new “Artificial Intelligence” Business Unit an..
2020ONCODESIGN : Announces the Creation of its new “Artificial Intelligence” Busin..
2020Oncodesign Société Anonyme Announces Consolidated Earnings Results for the Full Year En..
2020ONCODESIGN : Very Strong Improvement in Full-Year 2019 Results
2020ONCODESIGN : to Host Conference Call Following the 2019 Full-Year Results Publication
2020ONCODESIGN : and Servier reach a key first milestone in their strategic partnership on LRR..
2020ONCODESIGN : and Servier Reach a Key First Milestone in Their Strategic Partnership on LRR..
2020Servier and Oncodesign Reach a Key First Milestone in Their Strategic Partnership on LR..
2020ONCODESIGN : Announces a 33% Revenue Increase in 2019 and the Achievement of Financial Bre..
2020Oncodesign Société Anonyme Reports Earnings Results for the 2019
2019ONCODESIGN : Announces the Selection of Its First-in-Class RIPK2 Inhibitor Drug Candidate ..
2019Oncodesign Announces the Selection of Its First-In-Class Ripk2 Inhibitor Drug Candidate..
2019ONCODESIGN : Publication of an Article Presenting Promising Results for the Treatment of S..
2019Oncodesign Announces Publication of an Article Presenting Promising Results for the Tre..
2019ONCODESIGN : First-half 2019 results
2019ONCODESIGN : First-half 2019 Results
2019Oncodesign Reports Consolidated Earnings Results for the First Half of 2019; Confirms E..
2019ONCODESIGN :  Acceleration in Growth in the First Half of 2019, With Sales Rising 52% to €..
2019Oncodesign Announces Unaudited Consolidated Sales Results for the Half Year Ended June ..
2019ONCODESIGN : Reaches a Key Milestone in the Development of Its RIPK2 Program
2019ONCODESIGN Announces Key Milestone in the Development of Its RIPK2 Program
2019ONCODESIGN : 2018 Annual Results
2019Oncodesign Société Anonyme Announces Consolidated Earnings Results for the Full Year En..
2019PARKINSON'S DISEASE : Servier and Oncodesign Join Forces to Investigate New Line of Resear..
2019Oncodesign Société Anonyme Announces a Strategic Partnership for the Research and Devel..
2019ONCODESIGN IN 2018 : Second Consecutive Year of Strong Growth in Operating Revenue, up 20%..
2019Oncodesign Announces Unaudited Consolidated Financial Results for the Year Ended Decemb..
2018ONCODESIGN : Service Partnership Agreement between Oncodesign and Galderma
2018Oncodesign Société Anonyme and Galderma Announce Service Partnership Agreement
2018ONCODESIGN : Centre Georges François Leclerc Presents the Detailed Results of the First Tw..
2018ONCODESIGN Announces Detailed Results of the First Two Stages of Their Clinical Study o..
2018ONCODESIGN : 1st Half 2018 Results
2018ONCODESIGN Reports Consolidated Earnings Results for the First Half of 2018
2018PRECISION MEDICINE : Cap Digital and Medicen Paris-Region Team up with Oncodesign, Servier..
2018Oncodesign Furthers Cooperation with Eisai
2018ONCODESIGN : Furthers Its Cooperation with Eisai, Started 12 Years Ago
2018ONCODESIGN : Very Strong Revenue Growth of 58% to €9.2 Million in the First Half of 2018
2018ONCODESIGN Announces Revenue Results for the First Half of 2018
1  2  3Suiv.